Myovant Sciences Ltd. Operating Income (Loss) USD 2016 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Myovant Sciences Ltd. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2022.
  • Myovant Sciences Ltd. Operating Income (Loss) for the quarter ending December 31, 2022 was -$51.9 M, a 13.1% increase year-over-year.
  • Myovant Sciences Ltd. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$147 M, a 30.8% increase year-over-year.
  • Myovant Sciences Ltd. annual Operating Income (Loss) for 2021 was -$187 M, a 28.2% increase from 2020.
  • Myovant Sciences Ltd. annual Operating Income (Loss) for 2020 was -$261 M, a 5.13% increase from 2019.
  • Myovant Sciences Ltd. annual Operating Income (Loss) for 2019 was -$275 M, a 3.8% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$147 M -$51.9 M +$7.85 M +13.1% Oct 1, 2022 Dec 31, 2022 10-Q 2023-01-26
Q3 2022 -$155 M -$33.7 M -$15.4 M -83.8% Jul 1, 2022 Sep 30, 2022 10-Q 2022-10-26
Q2 2022 -$139 M -$9.36 M +$48 M +83.7% Apr 1, 2022 Jun 30, 2022 10-Q 2022-07-27
Q1 2022 -$187 M -$51.9 M +$25 M +32.5% Jan 1, 2022 Mar 31, 2022 10-K 2022-05-11
Q4 2021 -$212 M -$59.7 M +$18.6 M +23.7% Oct 1, 2021 Dec 31, 2021 10-Q 2023-01-26
Q3 2021 -$231 M -$18.3 M +$53.5 M +74.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 -$284 M -$57.3 M -$23.6 M -70.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 -$261 M -$76.9 M -$12.8 M -20% Jan 1, 2021 Mar 31, 2021 10-K 2022-05-11
Q4 2020 -$248 M -$78.3 M -$248 K -0.32% Oct 1, 2020 Dec 31, 2020 10-Q 2022-01-26
Q3 2020 -$248 M -$71.8 M -$4.43 M -6.57% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-26
Q2 2020 -$243 M -$33.7 M +$31.6 M +48.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 -$275 M -$64.1 M +$2.38 M +3.58% Jan 1, 2020 Mar 31, 2020 10-K 2022-05-11
Q4 2019 -$277 M -$78.1 M -$7.44 M -10.5% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 -$270 M -$67.4 M -$1.72 M -2.63% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$268 M -$65.3 M -$3.28 M -5.29% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$265 M -$66.5 M -$17.9 M -36.7% Jan 1, 2019 Mar 31, 2019 10-K 2021-05-11
Q4 2018 -$247 M -$70.6 M -$28.6 M -68.2% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 -$218 M -$65.7 M -$35.5 M -118% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$183 M -$62 M -$39.8 M -179% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$143 M -$48.6 M -$26.9 M -123% Jan 1, 2018 Mar 31, 2018 10-K 2019-05-24
Q4 2017 -$116 M -$42 M -$33.9 M -421% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 -$82.2 M -$30.2 M +$4.53 M +13.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$86.8 M -$22.2 M -$3.27 M -17.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$83.5 M -$21.8 M -$20.1 M -1215% Jan 1, 2017 Mar 31, 2017 10-K 2019-05-24
Q4 2016 -$63.4 M -$8.05 M Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-13
Q3 2016 -$34.7 M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$19 M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$1.66 M Feb 3, 2016 Mar 31, 2016 10-K 2018-06-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.